BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Galactosylceramides

a galactose moiety bound in glycosidic linkage to the hydroxyl group of ceramide. Their accumulation in tissue, due to a defect in beta-galactosidase, is the cause of galactosylceramide lipidosis or globoid cell leukodystrophy.

148+ PubMed studies analyzed · Evidence Score: 43.9

Research Domains

Galactosylceramides has been studied across 20 research domains including 🔥 Metabolic, 🛡️ Immunity, 🔬 Inflammation, 🔬 Oncology, 🫘 Kidney. The primary research focus is 🔥 Metabolic with 68% of studies addressing this area.

Loading evidence profile...

This evidence profile for Galactosylceramides is generated deterministically from 148 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.